Search research articles
Contact Us
Filters
Showing results (1-10 of 38) with videos related to
Page
of 4
Sort By:
Clinical Pharmacology and Therapeutics
|
June 15, 2020
Developing Drugs for Tissue-Agnostic Indications: A Paradigm Shift in Leveraging Cancer Biology for Precision Medicine
Nathan D Seligson, Todd C Knepper, Susanne Ragg, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
November 6, 2020
Adding the second T: Elevating STAR to START for behavioral interviewing
Jon M Apple, Jack C Guerci, Nathan D Seligson, et al.
NPJ Precision Oncology
|
June 20, 2025
Upregulation of POLE and proficient DNA repair are features of CIC::DUX4 sarcomas
Nathan D Seligson, Anjali Paragji, Feha Shahalam, et al.
The Annals of Pharmacotherapy
|
July 19, 2023
Atezolizumab as the First Systemic Therapy Approved for Alveolar Soft Part Sarcoma
Emilie J Bergsma, Mariam Elgawly, David Mancuso, et al.
Cancer Metastasis Reviews
|
February 6, 2020
Integration of EMT and cellular survival instincts in reprogramming of programmed cell death to anastasis
Souneek Chakraborty, Khalid Bashir Mir, Nathan D Seligson, et al.
Pharmacy (Basel, Switzerland)
|
June 1, 2022
Development of a Campus-Wide Community Service Initiative during a Pandemic
Kevan King, Hannah E Davis, Robin Moorman-Li, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
March 31, 2021
Evaluation of the timing of MRSA PCR nasal screening: How long can a negative assay be used to rule out MRSA-positive respiratory cultures?
Stephen C Turner, Nathan D Seligson, Bhavyata Parag, et al.
JCO Precision Oncology
|
February 2, 2022
Clinical Utility of CDK4/6 Inhibitors in Sarcoma: Successes and Future Challenges
Jocelyn Y Hsu, Nathan D Seligson, John L Hays, et al.
The Annals of Pharmacotherapy
|
October 19, 2020
Sacituzumab Govitecan-hziy: An Antibody-Drug Conjugate for the Treatment of Refractory, Metastatic, Triple-Negative Breast Cancer
John M Seligson, Alexandra M Patron, Michael J Berger, et al.
Research Square
|
June 5, 2026
Leveraging Dog Models to Uncover Human Cancer Insights
Geesa Daluwatumulle, Leslie A Smith, Nathan Glen, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 38) with videos related to
Sort By:
Page
of 4
Clinical Pharmacology and Therapeutics
|
June 15, 2020
Developing Drugs for Tissue-Agnostic Indications: A Paradigm Shift in Leveraging Cancer Biology for Precision Medicine
Nathan D Seligson, Todd C Knepper, Susanne Ragg, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
November 6, 2020
Adding the second T: Elevating STAR to START for behavioral interviewing
Jon M Apple, Jack C Guerci, Nathan D Seligson, et al.
NPJ Precision Oncology
|
June 20, 2025
Upregulation of POLE and proficient DNA repair are features of CIC::DUX4 sarcomas
Nathan D Seligson, Anjali Paragji, Feha Shahalam, et al.
The Annals of Pharmacotherapy
|
July 19, 2023
Atezolizumab as the First Systemic Therapy Approved for Alveolar Soft Part Sarcoma
Emilie J Bergsma, Mariam Elgawly, David Mancuso, et al.
Cancer Metastasis Reviews
|
February 6, 2020
Integration of EMT and cellular survival instincts in reprogramming of programmed cell death to anastasis
Souneek Chakraborty, Khalid Bashir Mir, Nathan D Seligson, et al.
Pharmacy (Basel, Switzerland)
|
June 1, 2022
Development of a Campus-Wide Community Service Initiative during a Pandemic
Kevan King, Hannah E Davis, Robin Moorman-Li, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
March 31, 2021
Evaluation of the timing of MRSA PCR nasal screening: How long can a negative assay be used to rule out MRSA-positive respiratory cultures?
Stephen C Turner, Nathan D Seligson, Bhavyata Parag, et al.
JCO Precision Oncology
|
February 2, 2022
Clinical Utility of CDK4/6 Inhibitors in Sarcoma: Successes and Future Challenges
Jocelyn Y Hsu, Nathan D Seligson, John L Hays, et al.
The Annals of Pharmacotherapy
|
October 19, 2020
Sacituzumab Govitecan-hziy: An Antibody-Drug Conjugate for the Treatment of Refractory, Metastatic, Triple-Negative Breast Cancer
John M Seligson, Alexandra M Patron, Michael J Berger, et al.
Research Square
|
June 5, 2026
Leveraging Dog Models to Uncover Human Cancer Insights
Geesa Daluwatumulle, Leslie A Smith, Nathan Glen, et al.
Page
of 4